----

----

| Nevada                                                        |   | 27-3984713                             |
|---------------------------------------------------------------|--------|----------------------------------------|
| (State or other jurisdiction ofincorporation or organization) |   | (I.R.S. EmployerIdentification Number) |
|                                                          |   |                                   |
| 760 State Route 10, Suite 203Whippany, NJ                     |   | 07981                                  |
| (Address of Principal Executive Offices)                      |   | (Zip Code)                             |

|   | Large accelerated filer | o                                                                 | Accelerated filer         | o |
|--------|-------------------------|-------------------------------------------------------------------|---------------------------|---|
|   | Non-accelerated filer   | o    (Do not check if a smaller reporting company) | Smaller reporting company | x |

----

Table of Contents

nt

|    |                  |                                                                                        | Page   |
|---------|-----------------------|---------------------------------------------------------------------------------------------|--------|
| Part I  | Financial Information | 1                                                                                           |
|    | Item 1                | Financial Statements                                                                        | 1      |
|    |                  | Balance Sheets (Unaudited)                                                                  | 2      |
|    |                  | Statements of Operations (Unaudited)                                                        | 3      |
|    |                  | Statements of Cash Flow (Unaudited)                                                         | 4      |
|    |                  | Notes to Financial Statements (Unaudited)                                                   | 5      |
|    | Item 2                | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 11     |
|    | Item 3                | Quantitative and Qualitative Disclosures About Market Risk                                  | 13     |
|    | Item 4                | Controls and Procedures                                                                     | 13     |
|    |                  |                                                                                        |   |
| Part II | Other Information     | 14                                                                                          |
|    | Item 1                | Legal Proceedings                                                                           | 14     |
|    | Item 1A               | Risk Factors                                                                                | 14     |
|    | Item 2                | Unregistered Sales of Equity Securities and Use of Proceeds                                 | 14     |
|    | Item 3                | Defaults Upon Senior Securities                                                             | 14     |
|    | Item 4                | (Reserved)                                                                                  | 14     |
|    | Item 5                | Other Information                                                                           | 14     |
|    | Item 6                | Exhibits                                                                                    | 14     |

----

Table of Contents

IN

id

----

Table of Contents

| PAZOO, INC                                                                                                                                                                                                     |   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
| CONSOLIDATED BALANCE SHEETS                                                                                                                                                                                    |   |
| (Unaudited)                                                                                                                                                                                                    |   |
|                                                                                                                                                                                                           |   |   |   |   |   |   |
|                                                                                                                                                                                                           |   |   |   |   |   |   |
|                                                                                                                                                                                                           |   | March 31,2015 |   |   | December 31,2014 |   |
|                                                                                                                                                                                                           |   |   |   |   |   |   |
| ASSETS                                                                                                                                                                                                         |   |   |   |   |   |   |
| Current assets:                                                                                                                                                                                                |   |   |   |   |   |   |
| Cash and cash equivalents                                                                                                                                                                                      |   | $ | 17,209 |   |   | $ | 733,637 |   |
| Accounts receivable                                                                                                                                                                                            |   |   | 88,770 |   |   |   | 87,949 |   |
| Stock subscription receivable                                                                                                                                                                                  |   |   | 12,999 |   |   |   | 18,253 |   |
| Inventories                                                                                                                                                                                                    |   |   | 2,668 |   |   |   | 2,668 |   |
| Prepaid expenses                                                                                                                                                                                               |   |   | 1,465 |   |   |   | 6,181 |   |
|                                                                                                                                                                                                           |   |   |   |   |   |   |   |   |
| Total current assets                                                                                                                                                                                           |   |   | 123,111 |   |   |   | 848,688 |   |
|                                                                                                                                                                                                           |   |   |   |   |   |   |   |   |
| Intangible assets                                                                                                                                                                                              |   |   | 200,000 |   |   |   | - |   |
|                                                                                                                                                                                                           |   |   |   |   |   |   |   |   |
| Total assets                                                                                                                                                                                                   |   | $ | 323,111 |   |   | $ | 848,688 |   |
|                                                                                                                                                                                                           |   |   |   |   |   |   |   |   |
| LIABILITIES AND STOCKHOLDERS' DEFICIT                                                                                                                                                                          |   |   |   |   |   |   |   |   |
| Current liabilities:                                                                                                                                                                                           |   |   |   |   |   |   |   |   |
| Accounts payable and accrued liabilities                                                                                                                                                                       |   | $ | 89,347 |   |   | $ | 84,189 |   |
| Loans payable                                                                                                                                                                                                  |   |   | 3,000 |   |   |   | 3,000 |   |
| Interest payable                                                                                                                                                                                               |   |   | 62,602 |   |   |   | 46,862 |   |
| Convertible debt, net of unamortized discounts of $242,308 and $413,898                                                                                                                                        |   |   | 621,133 |   |   |   | 895,664 |   |
| Derivative liabilities                                                                                                                                                                                         |   |   | 1,191,670 |   |   |   | 2,576,025 |   |
|                                                                                                                                                                                                           |   |   |   |   |   |   |   |   |
| Total current liabilities                                                                                                                                                                                      |   |   | 1,967,752 |   |   |   | 3,605,740 |   |
|                                                                                                                                                                                                           |   |   |   |   |   |   |   |   |
| Long-term liabilities:                                                                                                                                                                                         |   |   |   |   |   |   |   |   |
| Long-term portion of convertible debt, net of unamortized discounts of $690,124 and $783,668                                                                                                                   |   |   | 62,625 |   |   |   | 28,832 |   |
|                                                                                                                                                                                                           |   |   |   |   |   |   |   |   |
| Total long-term liabilities                                                                                                                                                                                    |   |   | 62,625 |   |   |   | 28,832 |   |
|                                                                                                                                                                                                           |   |   |   |   |   |   |   |   |
| Total liabilities                                                                                                                                                                                              |   | $ | 2,030,377 |   |   | $ | 3,634,572 |   |
|                                                                                                                                                                                                           |   |   |   |   |   |   |   |   |
| Stockholders' deficit                                                                                                                                                                                          |   |   |   |   |   |   |   |   |
| Common stock, $0.001 par value; 980,000,000 shares authorized, 501,850,585 and 193,030,398 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively                            |   |   | 501,850 |   |   |   | 193,031 |   |
| Convertible preferred stock, Ser. A, $0.001 par value, 10,000,000 shares authorized, 1,478,526 shares and 1,203,526 shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively.       |   |   | 1,479 |   |   |   | 1,204 |   |
| Preferred stock, Ser. B, $0.001 par value, 2,500,000 shares authorized, 1,637,500  and 1,187,500 shares issued and outstanding at March 31, 2015  and December 31, 2014, respectively |   |   | 1,637 |   |   |   | 1,187 |   |
| Convertible Preferred stock, Ser. C, $0.001 par value, 7,500,000 shares authorized, 580,000 and no shares issued and outstanding at March 31, 2015 and December 31, 2014, respectively                         |   |   | 580 |   |   |   | - |   |
| Additional paid-in capital                                                                                                                                                                                     |   |   | 7,131,665 |   |   |   | 4,438,643 |   |
| Accumulated deficit                                                                                                                                                                                            |   |   | (9,344,477 | ) |   |   | (7,419,949 | ) |
|                                                                                                                                                                                                           |   |   |   |   |   |   |   |   |
| Total stockholders' deficit                                                                                                                                                                                    |   |   | (1,707,266 | ) |   |   | (2,785,884 | ) |
|                                                                                                                                                                                                           |   |   |   |   |   |   |   |   |
| Total liabilities and stockholders' equity deficit                                                                                                                                                             |   | $ | 323,111 |   |   | $ | 848,688 |   |

----

Table of Contents

| PAZOO, INC.                                                    |   |
|----------------------------------------------------------------|--------|
| CONSOLIDATED STATEMENTS OF OPERATIONS                          |   |
| (Unaudited)                                                    |   |
|                                                           |   |
|                                                           |   | Three Months Ended |   |
|                                                           |   | March 31, |   |
|                                                           |   | 2015 |   |   | 2014 |   |
|                                                           |   |   |   |   |   |   |
| Revenues                                                       |   |   |   |   |   |   |
| Merchandise sales                                              |   | $ | - |   |   | $ | 218 |   |
| Advertising sales                                              |   |   | 20,233 |   |   |   | 17,109 |   |
| Total revenues                                                 |   |   | 20,233 |   |   |   | 17,327 |   |
| Cost of goods sold                                             |   |   |   |   |   |   |   |   |
| Merchandise sales                                              |   |   | - |   |   |   | 325 |   |
| Total cost of goods sold                                       |   |   | - |   |   |   | 325 |   |
| Gross profit                                                   |   |   | 20,233 |   |   |   | 17,002 |   |
|                                                           |   |   |   |   |   |   |   |   |
| Selling, general and administrative expenses                   |   |   | 1,080,862 |   |   |   | 206,458 |   |
| Professional fees                                              |   |   | 228,521 |   |   |   | 35,433 |   |
| Website setup                                                  |   |   | 57,120 |   |   |   | 22,408 |   |
| Total operating expenses                                       |   |   | 1,366,503 |   |   |   | 264,299 |   |
|                                                           |   |   |   |   |   |   |   |   |
| Loss from operations                                           |   |   | (1,346,270 | ) |   |   | (247,297 | ) |
|                                                           |   |   |   |   |   |   |   |   |
| Other expenses:                                                |   |   |   |   |   |   |   |   |
| Gain/(loss) on derivative liability                            |   |   | 439,113 |   |   |   | (376,187 | ) |
| Impairment loss on investments                                 |   |   | (499,000 | ) |   |   | - |   |
| Interest expense                                               |   |   | (518,371 | ) |   |   | (23,804 | ) |
|                                                           |   |   |   |   |   |   |   |   |
| Net loss                                                       |   | $ | (1,924,528 | ) |   | $ | (647,288 | ) |
| Series A preferred stock dividend                              |   |   | (8,962 | ) |   |   | (5,672 | ) |
| Net loss attributable to common stockholders                   |   |   | (1,933,490 | ) |   |   | (652,960 | ) |
|                                                           |   |   |   |   |   |   |   |   |
| Weighted average common shares outstanding - Basic and diluted |   |   | 294,471,692 |   |   |   | 105,994,083 |   |
|                                                           |   |   |   |   |   |   |   |   |
| Net loss per common share - Basic and diluted                  |   | $ | (0.01 | ) |   | $ | (0.01 | ) |

----

Table of Contents

| PAZOO, INC.                                                                                                 |   |
|-------------------------------------------------------------------------------------------------------------|--------|
| CONSOLIDATED STATEMENTS OF CASH FLOWS                                                                       |   |
| (Unaudited)                                                                                                 |   |
|                                                                                                        |   | Three Months Ended |   |
|                                                                                                        |   | March 31, |   |
|                                                                                                        |   | 2015 |   |   | 2014 |   |
|                                                                                                        |   |   |   |   |   |   |
| Cash flows from operating activities:                                                                       |   |   |   |   |   |   |
| Net loss                                                                                                    |   | $ | (1,924,528 | ) |   | $ | (647,288 | ) |
| Adjustments to reconcile net loss to net cash used in operating activities:                                 |   |   |   |   |   |   |   |   |
| Stock-based compensation                                                                                    |   |   | 862,800 |   |   |   | 110,991 |   |
| (Gain)/loss on derivative liabilities                                                                       |   |   | (439,113 | ) |   |   | 376,187 |   |
| Impairment loss on equity method investment                                                                 |   |   | 499,000 |   |   |   | - |   |
| Amortization of debt discounts                                                                              |   |   | 451,693 |   |   |   | 17,804 |   |
|         Loss on true-up of convertible notes                             |   |   | 34,383 |   |   |   | - |   |
|         Additional common shares issued for true-up of convertible notes |   |   | 51,470 |   |   |   | - |   |
| Changes in operating assets and liabilities:                                                                |   |   |   |   |   |   |   |   |
| Accounts receivable                                                                                         |   |   | (821 | ) |   |   | (7,537 | )  |
| Stock subscription receivable                                                                               |   |   | 5,254 |   |   |   | - |   |
| Inventories                                                                                                 |   |   | - |   |   |   | 1,565 |   |
| Prepaid expenses and other current assets                                                                   |   |   | 4,716 |   |   |   | (22,147 | ) |
| Accounts payable and accrued liabilities                                                                    |   |   | 5,159 |   |   |   | 12,076 |   |
| Interest payable                                                                                            |   |   | 66,679 |   |   |   | 6,000 |   |
| Net cash used in operating activities                                                                       |   |   | (383,308 | ) |   |   | (152,349 | ) |
|                                                                                                        |   |   |   |   |   |   |   |   |
| Cash flows from investing activities:                                                                       |   |   |   |   |   |   |   |   |
| Deposit made on acquisition of investment                                                                   |   |   | - |   |   |   | (50,000 | )  |
| Cash paid for intangible asset                                                                              |   |   | (200,000 | ) |   |   | - |   |
| Equity investment in equity method investee                                                                 |   |   | (499,000 | ) |   |   | - |   |
| Net cash used in investing activities                                                                       |   |   | (699,000 | ) |   |   | (50,000 | ) |
|                                                                                                        |   |   |   |   |   |   |   |   |
| Cash flows from financing activities:                                                                       |   |   |   |   |   |   |   |   |
| Borrowings on convertible note, net of original issue discounts                                             |   |   | 82,500 |   |   |   | 55,000 |   |
| Proceeds from issuing common stock                                                                          |   |   | 48,380 |   |   |   | - |   |
| Proceeds from exercise of Series A preferred warrants                                                       |   |   | - |   |   |   | 40,000 |   |
| Proceeds from sale of Series A preferred stock and warrants                                                 |   |   |         235,000 |   |   |   | 100,000 |   |
| Net cash provided by financing activities                                                                   |   |   | 365,880 |   |   |   | 195,000 |   |
|                                                                                                        |   |   |   |   |   |   |   |   |
| Net increase in cash and cash equivalents                                                                   |   |   | (716,428 | ) |   |   | (7,349 | ) |
| Cash and cash equivalents beginning of period                                                               |   |   | 733,637 |   |   |   | 35,848 |   |
| Cash and cash equivalents end of period                                                                     |   | $ | 17,209 |   |   | $ | 28,499 |   |
|                                                                                                        |   |   |   |   |   |   |   |   |
| Supplemental Disclosure of Cash Flows Information                                                           |   |   |   |   |   |   |   |   |
| Cash paid for interest                                                                                      |   | $ | - |   |   | $ | - |   |
| Cash paid for income taxes                                                                                  |   |   | - |   |   |   | - |   |
|                                                                                                        |   |   |   |   |   |   |   |   |
| Noncash Investing and Financing Activities                                                                  |   |   |   |   |   |   |   |   |
| Common stock issued for the conversion of Series A preferred stock                                          |   | $ | 60,000 |   |   | $ | 1,700 |   |
| Debt discounts due to derivative liabilities                                                                |   |   | 181,803 |   |   |   | 60,500 |   |
| Payments of accounts payable by third party                                                                 |   |   | - |   |   |   | 2,075 |   |
| Original issue discount on convertible note                                                                 |   |   | - |   |   |   | 5,500 |   |
| Resolution of derivative liabilities                                                                        |   |   | 1,126,245 |   |   |   | - |   |
| Common shares issued for conversion of debt and interest                                                    |   |   | 679,251 |   |   |   | - |   |

----

Table of Contents

o,

----

Table of Contents

|   | 3,858,333   |   | shares for third-party services valued at $15,550                                      |
|--------|-------------|--------|----------------------------------------------------------------------------------------|
|   | 5,460,125   |   | shares issued for cash for cash proceeds of $48,380                                    |
|   | 7,918,528   |   | shares issued for true-up of loan conversion valued and expensed at  $51,470 |
|   | 60,000,000  |   | shares resulting from Series A Preferred Stock holders converting 600,000 shares       |
|   | 231,583,201 |   | shares resulting from debt holders converting $679,251 of debt into common stock       |
|   | 308,820,187 |   | shares issued total                                                                    |
|   | 193,030,398 |   | shares at December 31, 2014                                                            |
|   | 501,850,585 |   | shares at March 31, 2015                                                               |

|   | (600,000  | )      | shares converted into 60,000,000 common shares |
|--------|-----------|--------|------------------------------------------------|
|   | 875,000   |   | shares issued for $235,000 in cash             |
|   | 275,000   |   | shares total                                   |
|   | 1,203,526 |   | shares at December 31, 2014                    |
|   | 1,478,526 |   | shares at March 31, 2015                       |

|                            |   | Warrants |      |   | Weighted Average Exercise Price |   |
|---------------------------------|--------|----------|-----------|--------|---------------------------------|--------|
|                            |   |     |      |   |                            |   |   |   |
| Outstanding - December 31, 2014 |   |     | 1,030,226 |   |                            | $      | 2.23 |   |
| Granted                         |   |     | 1,750,000 |   |                            |   | 0.50 |   |
| Forfeited/Canceled              |   |     | -         |   |                            |   | - |   |
| Exercised                       |   |     | -         |   |                            |   | - |   |
| Outstanding - March 31, 2015    |   |     | 2,780,726 |   |                            |   | 1.18 |   |
| Exercisable - March 31, 2015    |   |     | 2,780,726 |   |                            | $      | 1.18 |   |

----

Table of Contents

|                            |   | Warrants |      |   | Weighted Average Exercise Price |   |
|---------------------------------|--------|----------|-----------|--------|---------------------------------|--------|
|                            |   |     |      |   |                            |   |   |   |
| Outstanding - December 31, 2014 |   |     | 6,130,470 |   |                            | $      | 0.05 |   |
| Granted                         |   |     | -         |   |                            |   | - |   |
| Forfeited/Canceled              |   |     | -         |   |                            |   | 0.05 |   |
| Exercised                       |   |     | -         |   |                            |   | - |   |
| Outstanding - March 31, 2015    |   |     | 6,130,470 |   |                            |   | 0.05 |   |
| Exercisable - March 31, 2015    |   |     | 6,130,470 |   |                            | $      | 0.05 |   |

----

Table of Contents

|                                      |   | Short Term |      |   | Long Term |   |     | Total  |   |   |
|-------------------------------------------|--------|------------|-----------|--------|-----------|--------|----------|--------|--------|--------|
|                                      |   |       |      |   |      |   |     |   |   |   |
| Balance as of December 31, 2014 - Net     |   | $          | 895,664   |   |      | $      | 28,832   |   |   | $      | 924,496 |   |   |
| Add back:  unamortized discount |   |       | (413,898  | )      |      |   | (783,668 | )      |   |   | (1,197,566 | ) |   |
| Balance as of December 31, 2014 - Gross   |   | $          | 1,309,562 |   |      | $      | 812,500  |   |   | $      | 2,122,062 |   |   |
| Cash additions                            |   |       | 52,500    |   |      |   | 30,000   |   |   |   | 82,500 |   |   |
| Non-cash additions                        |   |       | 34,383    |   |      |   | -        |   |   |   | 34,383 |   |   |
| Cash payments                             |   |       | ( -  | )      |      |   | ( - | )      |   |   | ( - | ) |   |
| Conversions                               |   |       | (572,756  | )      |      |   | (55,556  | )      |   |   | (628,312 | ) | (a) |
| Original issue discount                   |   |       | 5,556     |   |      |   | -        |   |   |   | 5,556 |   |   |
| Total                                     |   |       | 829,245   |   |      |   | 786,944  |   |   |   | 1,616,189 |   |   |
| Less:  unamortized discount     |   |       | (208,113  | )      |      |   | (724,319 | )      |   |   | (932,432 | ) |   |
| Balance as of March 31, 2015              |   | $          | 621,132   |   |      | $      | 62,625   |   |   | $      | 686,757 |   |   |

| (a) | The Statement of Cash Flows shows $679,251 which consists of $628,312 in principal plus $50,939 in interest.  Both were converted into common shares. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                    | March 31, 2015   |   |
|-------------------------|------------------|--------|
|                    |             |   |   |
| Dividend yield:         |             |   | 0 |   |
| Expected volatility     | 144.0% to 219.0% |   |
| Risk free interest rate | 0.03% to 1.37%   |   |
| Expected life (years)   | 0.25 to 4.91     |   |

----

Table of Contents

| Balance as of December 31, 2014     |   | $      | 2,576,025  |   |
|-------------------------------------|--------|--------|------------|--------|
|                                |   |   |       |   |
| Debt discount                       |   |   | 181,003    |   |
| Original issuance discount          |   |   | -          |   |
| Extinguished                        |   |   | (1,126,245 | )      |
| Change in fair value                |   |   | (439,113   | )      |
|                                |   |   |       |   |
| Ending balance as of March 31, 2015 |   | $      | 1,191,670  |   |

----

Table of Contents

| Recurring Fair Value Measurements          |   | Level 1 |   |   | Level 2 |   |   | Level 3 |   |   | Total     |   |
|--------------------------------------------|--------|---------|--------|--------|---------|--------|--------|---------|--------|--------|-----------|--------|
|                                       |   |    |   |   |    |   |   |    |   |   |      |   |
| LIABILITIES:                               |   |    |   |   |    |   |   |    |   |   |      |   |
| Derivative liabilities - March 31, 2015    |   |    | -      |   |    |   | -      |    |   |   | 1,191,670 |   |   |   | 1,191,670 |   |
| Derivative liabilities - December 31, 2014 |   |    | -      |   |    |   | -      |    |   |   | 2,576,025 |   |   |   | 2,576,025 |   |

| ● | Investors converted $282,067 of Convertible Promissory Notes into 115,461,060 common shares.   |
|---------|----------------------------------------------------------------------------------------------------------|

| ● | Investors converted $435,000 of Convertible Preferred Series A Stock into 43,500,000 shares of common stock. |
|---------|--------------------------------------------------------------------------------------------------------------|

| ● | We issued 1,437,500 of Series A Preferred Stock for $225,000 in accordance with Investment Agreement No. 5 and No. 6. |
|---------|-----------------------------------------------------------------------------------------------------------------------|

| ● | The Company acquired the remaining 60% of MA & Associates in exchange for an aggregate total of 1,000,000 shares of the Company’s Preferred C shares of stock. The Company now owns 100% of MA & Associates and is consolidating this investment.  In 2014, the company accounted for this investment under the equity method. The Agreement is attached here as Exhibit 99.3. |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ● | The Company formed a wholly owned subsidiary called CannabisKing Distribution LLC.  This subsidiary will distribute ancillary non-regulated products at various testing laboratories across the country. |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ● | The Company borrowed an aggregate of $780,000 under convertible notes with the following terms:       Interest rates  8.0% to 12.0%     Conversion rates  $0.0065 to $0.02     Maturity dates  November 2015 to April 2020 |
|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ● | The Company paid back an aggregate total of $373,382 in Convertible Notes. |
|---------|----------------------------------------------------------------------------|

----

Table of Contents

nd

|   | ● | Advertising Revenue from Our Website, www.pazoo.com.   Through advertising providers and agencies, pazoo.com is paid for every ad impression that appears on a page for which a visitor goes to. As we build our visitor base, ad revenue will increase. However, just having the traffic does not effectively increase advertising revenue. To get the full value of each visitor, the time on site must be long enough so that a visitor is interested in going to multiple pages for which there are ads on each page. The only way this will transpire is if the visitor’s experience is gratifying. This is why pazoo.com is so focused on quality content that’s interesting and informative. A bad visitor experience will result in a low time on site and fewer page views. Internet tracking tools have much improved over the past decade and will continue to improve in the coming years, especially when it comes to advertising and overall website analytics. Pazoo continues to constantly improve is this area at all times. Pazoo.com has seen a strong increase in its viewership as shown by the recent average time spent on site for the period March 2014 to May 2014 of five minutes and forty seconds versus three minutes and twenty-seven seconds for the same time period from December 2013 to February 2014 with the same amount of page views. Pazoo.com has a unique and compelling online marketing platform. Pazoo.com offers the following important marketing advantages to its target audiences: |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 1. | A comprehensive solution as a content source – information on a full spectrum of disciplines within the health and wellness marketplace; |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2. | Health and wellness experts that have expertise in these varied disciplines and write about their areas expertise; and |
|--------|----|------------------------------------------------------------------------------------------------------------------------|

|   | 3. | Content that is both for the health and wellness of people as well as their pets (over 60% of American homes have pets). |
|--------|----|--------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|   | ● | E-commerce.   Our e-commerce offerings will increase as we build the traffic coming to pazoo.com. In this way we could establish a revenue source over and above advertising to increase the value of each visitor. We have the following e-commerce elements ready for an activated marketing program: |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 1. | An e-commerce platform that is functional; |
|--------|----|--------------------------------------------|

|   | 2. | Relationships with manufacturers, distributors and other e-commerce companies so that increasing product offerings will not be time consuming; |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 3. | Members on the pazoo.com content team with merchandising experience: i.e. a Pazoo expert is buyer of pet products for a large pet retailer; and |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 4. | Members on the pazoo.com content team that are experienced in e-commerce marketing; i.e. we will look to offer our consumers low cost and timely delivery of product by negotiating with shipping companies to offer a flat rates on various products. |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | ● | Pharmaceutical Testing Facilities.   We entered this arena through our recent acquisition of a 40% minority equity stake in MA & Associates, LLC. MA & Associates was launched in September of 2013 to provide quality control services to the medical cannabis industry. MA & Associates’ primary mission is to protect the public health by providing infrastructure and analytical services to legally authorized distributors and producers of cannabis and to regulators tracking their operations. The company will provide the medical cannabis industry guidelines on how the regulation and inspection by public health authorities is to be implemented. MA & Associates’ primary customer base includes all of the licensed cannabis cultivators, in the State of Nevada, and their customers are required by law to have their products tested before they can be transferred to the dispensaries. As such, we are in a unique position to provide the mandated health and safety testing upon which this burgeoning industry must hinge. |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

lo

ro

----

Table of Contents

NF

ce

k 

gi

 S

er

nf

ib

| ExhibitNumber |   | Description                                                                                                                                                        |
|---------------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|          |   |                                                                                                                                                               |
| 31.1          |   | Certification of David Cunic, Chairman and Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.                              |
| 31.2          |   | Certification of Ben Hoehn, Acting Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.                                      |
| 32.1          |   | Certification of David Cunic, Chief Executive Officer pursuant to 18 U.S.C Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.      |
| 32.2          |   | Certification of Ben Hoehn, Acting Chief Financial Officer pursuant to 18 U.S.C Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 99.1          |   | ICPI Investment Agreement No. 4                                                                                                                                    |
| 99.2          |   | 3-17-14 Board Resolution                                                                                                                                           |
| 99.3          |   | MA & Associates Limited Liability Company Membership Interest Purchase Agreement                                                                               |

----

Table of Contents

| June 23, 2015 | PAZOO, INC.                                                                                          |   |
|---------------|------------------------------------------------------------------------------------------------------|--------|
|          |                                                                                                 |   |
|          | /s/ David M. Cunic                                                                                   |   |
|          | David M. Cunic                                                                                       |   |
|          | Chief Executive Officer                                                                              |   |
|          |                                                                                                 |   |
|          |                                                                                                 |   |
| June 23, 2015 | PAZOO, INC.                                                                                          |   |
|          |                                                                                                 |   |
|          | /s/ Ben Hoehn                                                                                        |   |
|          | Ben Hoehn,                                                                                           |   |
|          | Chief Operating Officer, Acting Chief Financial Officer (Principal Financial and Accounting Officer) |   |

----